Median Diagnostics Inc. engages in the manufacture and supply of in vitro diagnostic products for animal diseases and raw materials for human disease diagnosis. It operates through the following business divisions: Enzyme immunoassay method, Gene amplification diagnosis, Rapid diagnosis and Raw materials. The Enzyme immunoassay method business division offers enzyme-linked immunosorbent assay for bovine, swine and poultry. The Gene amplification diagnosis business division provides polymerase chain reaction kits. The Rapid diagnosis business division offers rapid kits such as companion animals rapid kit, livestock and poultry animals rapid kit. The Raw materials business division provides biologicals such anti-hemoglobin, malaria plasmodium and anti-malaria. The company was founded on October 18, 1999 and is headquartered in Chuncheon-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company